Impaired epithelial wound healing and EGFR signaling pathways in the corneas of diabetic rats

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 6, 2011, Pages 3301-3308

  Xu, Keping ^a   Yu, Fu Shin X ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BAD; PROTEIN KINASE B; BAD PROTEIN, RAT; EGFR PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA INJURY; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; STAINING; WESTERN BLOTTING; WOUND CLOSURE; WOUND HEALING IMPAIRMENT; ANIMAL; CORNEA DISEASE; EXPERIMENTAL DIABETES MELLITUS; INJURY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SPRAGUE DAWLEY RAT; WOUND HEALING;

ANIMALS; BCL-ASSOCIATED DEATH PROTEIN; BLOTTING, WESTERN; CORNEAL DISEASES; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; EPITHELIUM, CORNEAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; PHOSPHORYLATION; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 79960975348     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5670     Document Type: Article

References (62)

1. Clark CM Jr, Lee DA. Prevention and treatment of the complications of diabetes mellitus. N Engl J Med. 1995;332:1210-1217.
2. Kaji Y. Prevention of diabetic keratopathy. Br J Ophthalmol. 2005; 89:254-255.
3. Friend J, Ishii Y, Thoft RA. Corneal epithelial changes in diabetic rats. Ophthalmic Res. 1982;14:269-278.
4. Taylor HR, Kimsey RA. Corneal epithelial basement membrane changes in diabetes. Invest Ophthalmol Vis Sci. 1981;20:548-553.
5. Azar DT, Spurr-Michaud SJ, Tisdale AS, Gipson IK. Altered epithelial-basement membrane interactions in diabetic corneas. Arch Ophthalmol. 1992;110:537-540.
6. Zagon IS, Sassani JW, McLaughlin PJ. Insulin treatment ameliorates impaired corneal reepithelialization in diabetic rats. Diabetes. 2006;55:1141-1147.
7. Inoue K, Okugawa K, Amano S, et al. Blinking and superficial punctate keratopathy in patients with diabetes mellitus. Eye (Lond). 2005;19:418-421.
8. Rehany U, Ishii Y, Lahav M, Rumelt S. Ultrastructural changes in corneas of diabetic patients: an electron-microscopy study. Cornea. 2000;19:534-538.
9. Saini JS, Khandalavla B. Corneal epithelial fragility in diabetes mellitus. Can J Ophthalmol. 1995;30:142-146.
10. Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell. 2007;129:1261-1274.
11. Panka DJ, Atkins MB, Mier JW. Targeting the mitogen-activated protein kinase pathway in the treatment of malignant melanoma. Clin Cancer Res. 2006;12:2371s-2375s.
12. Schultz RO, Van Horn DL, Peters MA, Klewin KM, Schutten WH. Diabetic keratopathy. Trans Am Ophthalmol Soc. 1981;79:180-199.
13. Pflugfelder SC. Is autologous serum a tonic for the ailing corneal epithelium? Am J Ophthalmol. 2006;142:316-317.
14. Brightbill FS, Myers FL, Bresnick GH. Postvitrectomy keratopathy. Am J Ophthalmol. 1978;85:651-655.
15. Fukushi S, Merola LO, Tanaka M, Datiles M, Kinoshita JH. Reepithelialization of denuded corneas in diabetic rats. Exp Eye Res. 1980;31:611-621.
16. Schulze SD, Sekundo W, Kroll P. Autologous serum for the treatment of corneal epithelial abrasions in diabetic patients undergoing vitrectomy. Am J Ophthalmol. 2006;142:207-211.
17. Klocek MS, Sassani JW, McLaughlin PJ, Zagon IS. Naltrexone and insulin are independently effective but not additive in accelerating corneal epithelial healing in type I diabetic rats. Exp Eye Res. 2009;89:686-692.
18. Zagon IS, Klocek MS, Sassani JW, McLaughlin PJ. Use of topical insulin to normalize corneal epithelial healing in diabetes mellitus. Arch Ophthalmol. 2007;125:1082-1088.
19. Zagon IS, Sassani JW, Carroll MA, McLaughlin PJ. Topical application of naltrexone facilitates reepithelialization of the cornea in diabetic rabbits. Brain Res Bull. 2010;81:248-255.
20. Saghizadeh M, Kramerov AA, Yu FS, Castro MG, Ljubimov AV. Normalization of wound healing and diabetic markers in organ cultured human diabetic corneas by adenoviral delivery of c-Met gene. Invest Ophthalmol Vis Sci. 2010;51:1970-1980.
21. Saghizadeh M, Brown DJ, Castellon R, et al. Overexpression of matrix metalloproteinase-10 and matrix metalloproteinase-3 in human diabetic corneas: a possible mechanism of basement membrane and integrin alterations. Am J Pathol. 2001;158:723-734.
22. Azar DT, Spurr-Michaud SJ, Tisdale AS, Gipson IK. Decreased penetration of anchoring fibrils into the diabetic stroma: a morphometric analysis. Arch Ophthalmol. 1989;107:1520-1523.
23. Rosenberg ME, Tervo TM, Immonen IJ, Muller LJ, Gronhagen-Riska C, Vesaluoma MH. Corneal structure and sensitivity in type 1 diabetes mellitus. Invest Ophthalmol Vis Sci. 2000;41:2915-2921.
24. Ishida N, Rao GN, del Cerro M, Aquavella JV. Corneal nerve alterations in diabetes mellitus. Arch Ophthalmol. 1984;102: 1380-1384.
25. Ramos-Remus C, Suarez-Almazor M, Russell AS. Low tear production in patients with diabetes mellitus is not due to Sjogren's syndrome. Clin Exp Rheumatol. 1994;12:375-380.
26. Inoue K, Kato S, Ohara C, Numaga J, Amano S, Oshika T. Ocular and systemic factors relevant to diabetic keratoepitheliopathy. Cornea. 2001;20:798-801.
27. Rao GN. Dr. P. Siva Reddy Oration. Diabetic keratopathy. Indian J Ophthalmol. 1987;35:16-36.
28. Xu KP, Li Y, Ljubimov AV, Yu FS. High glucose suppresses epidermal growth factor receptor/phosphatidylinositol 3-kinase/Akt signaling pathway and attenuates corneal epithelial wound healing. Diabetes. 2009;58:1077-1085.
29. Akhtar S, Almubrad T, Bron AJ, Yousif MH, Benter IF. Role of epidermal growth factor receptor (EGFR) in corneal remodelling in diabetes. Acta Ophthalmol. 2009;87:881-889.
30. Shah NT, Kris MG, Pao W, et al. Practical management of patients with non-small-cell lung cancer treated with gefitinib. J Clin Oncol. 2005;23:165-174.
31. Specenier P, Koppen C, Vermorken JB. Diffuse punctate keratitis in a patient treated with cetuximab as monotherapy. Ann Oncol. 2007;18:961-962.
32. Gonul B, Koz M, Ersoz G, Kaplan B. Effect of EGF on the corneal wound healing of alloxan diabetic mice. Exp Eye Res. 1992;54: 519-524.
33. Ahren B, Stern JS, Gingerich RL, Curry DL, Havel PJ. Glucagon secretory response to hypoglycaemia, adrenaline and carbachol in streptozotocin-diabetic rats. Acta Physiol Scand. 1995;155:215-221.
34. Nakamura M, Sato N, Chikama T, Hasegawa Y, Nishida T. Fibronectin facilitates corneal epithelial wound healing in diabetic rats. Exp Eye Res. 1997;64:355-359.
35. Beebe DC, Masters BR. Cell lineage and the differentiation of corneal epithelial cells. Invest Ophthalmol Vis Sci. 1996;37:1815-1825.
36. Zagon IS, Jenkins JB, Sassani JW, et al. Naltrexone, an opioid antagonist, facilitates reepithelialization of the cornea in diabetic rat. Diabetes. 2002;51:3055-3062.
37. Chikama T, Wakuta M, Liu Y, Nishida T. Deviated mechanism of wound healing in diabetic corneas. Cornea. 2007;26:S75-S81.
38. Wakuta M, Morishige N, Chikama T, Seki K, Nagano T, Nishida T. Delayed wound closure and phenotypic changes in corneal epithelium of the spontaneously diabetic Goto-Kakizaki rat. Invest Ophthalmol Vis Sci. 2007;48:590-596.
39. Hallberg CK, Trocme SD, Ansari NH. Acceleration of corneal wound healing in diabetic rats by the antioxidant trolox. Res Commun Mol Pathol Pharmacol. 1996;93:3-12.
40. Hatchell DL, Magolan JJ Jr, Besson MJ, Goldman AI, Pederson HJ, Schultz KJ. Damage to the epithelial basement membrane in the corneas of diabetic rabbits. Arch Ophthalmol. 1983;101:469-471.
41. Azar DT, Gipson IK. Repair of the corneal epithelial adhesion structures following keratectomy wounds in diabetic rabbits. Acta Ophthalmol Suppl. 1989;192:72-79.
42. Sato N, Nakamura M, Chikama T, Nishida T. Abnormal deposition of laminin and type IV collagen at corneal epithelial basement membrane during wound healing in diabetic rats. Jpn J Ophthalmol. 1999;43:343-347.
43. Takahashi H, Akiba K, Noguchi T, et al. Matrix metalloproteinase activity is enhanced during corneal wound repair in high glucose condition. Curr Eye Res. 2000;21:608-615.
44. Lockwood A, Hope-Ross M, Chell P. Neurotrophic keratopathy and diabetes mellitus. Eye (Lond). 2006;20:837-839.
45. Datiles MB, Kador PF, Fukui HN, Hu TS, Kinoshita JH. Corneal re-epithelialization in galactosemic rats. Invest Ophthalmol Vis Sci. 1983;24:563-569.
46. Watanabe H, Katakami C, Miyata S, Negi A. Corneal disorders in KKAy mouse: a type 2 diabetes model. Jpn J Ophthalmol. 2002; 46:130-139.
47. Yucel I, Yucel G, Akar Y, Demir N, Gurbuz N, Aslan M. Transmission electron microscopy and autofluorescence findings in the cornea of diabetic rats treated with aminoguanidine. Can J Ophthalmol. 2006;41:60-66.
48. Nakamura M, Kawahara M, Morishige N, Chikama T, Nakata K, Nishida T. Promotion of corneal epithelial wound healing in diabetic rats by the combination of a substance P-derived peptide (FGLM-NH2) and insulin-like growth factor-1. Diabetologia. 2003; 46:839-842.
49. Zieske JD, Takahashi H, Hutcheon AE, Dalbone AC. Activation of epidermal growth factor receptor during corneal epithelial migration. Invest Ophthalmol Vis Sci. 2000;41:1346-1355.
50. Block ER, Klarlund JK. Wounding sheets of epithelial cells activates the epidermal growth factor receptor through distinct shortand long-range mechanisms. Mol Biol Cell. 2008;19:4909-4917.
51. McClintock JL, Ceresa BP. Transforming growth factor-α enhances corneal epithelial cell migration by promoting EGFR recycling. Invest Ophthalmol Vis Sci. 2010;51:3455-3461.
52. Xu KP, Ding Y, Ling J, Dong Z, Yu FS. Wound-induced HB-EGF ectodomain shedding and EGFR activation in corneal epithelial cells. Invest Ophthalmol Vis Sci. 2004;45:813-820.
53. Saghizadeh M, Kramerov AA, Yaghoobzadeh Y, et al. Adenovirusdriven overexpression of proteinases in organ-cultured normal human corneas leads to diabetic-like changes. Brain Res Bull. 2010;81:262-272.
54. Maguen E, Rabinowitz YS, Regev L, Saghizadeh M, Sasaki T, Ljubimov AV. Alterations of extracellular matrix components and proteinases in human corneal buttons with INTACS for post-laser in situ keratomileusis keratectasia and keratoconus. Cornea. 2008; 27:565-573.
55. Lyu J, Lee KS, Joo CK. Transactivation of EGFR mediates insulinstimulated ERK1/2 activation and enhanced cell migration in human corneal epithelial cells. Mol Vis. 2006;12:1403-1410.
56. Xu KP, Yu FS. Cross talk between c-Met and epidermal growth factor receptor during retinal pigment epithelial wound healing. Invest Ophthalmol Vis Sci. 2007;48:2242-2248.
57. Korb M, Rust AG, Thorsson V, et al. The Innate Immune Database (IIDB). BMC Immunol. 2008;9:7.
58. Franke TF. PI3K/Akt: getting it right matters. Oncogene. 2008;27: 6473-6488.
59. Ramos JW. The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells. Int J Biochem Cell Biol. 2008;40:2707-2719.
60. Matheny RW Jr, Adamo ML. Current perspectives on Akt Aktivation and Akt-ions. Exp Biol Med (Maywood). 2009;234:1264-1270.
61. Danial NN. BAD: undertaker by night, candyman by day. Oncogene. 2008;27(suppl 1):S53-S70.
62. Fernando RI, Wimalasena J. Estradiol abrogates apoptosis in breast cancer cells through inactivation of BAD: Ras-dependent nongenomic pathways requiring signaling through ERK and Akt. Mol Biol Cell. 2004;15:3266-3284.